FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292113114> ?p ?o ?g. }

• W4292113114 endingPage "4791" @default.
• W4292113114 startingPage "4779" @default.
• W4292113114 abstract "The blood pressure (BP) control mechanism for mineralocorticoid receptor blockers is unclear, and analysis of their use as a single agent in the clinical setting is required to resolve this uncertainty. There is a paucity of data on esaxerenone monotherapy assessing its long-term antihypertensive effect and urinary biomarkers.This post hoc exploratory substudy of a long-term phase 3 study evaluated the effect of esaxerenone monotherapy (2.5 or 5 mg/day) in treatment-naïve patients who continued the therapy during the 52-week study period (n = 25). In addition to blood biomarkers, urinary biomarkers were also assessed in 24-h urine collection samples.Esaxerenone monotherapy was associated with consistent reductions in systolic/diastolic BP in the substudy population (- 23.5/- 13.1 mmHg at week 52, p < 0.001 vs baseline). Plasma aldosterone concentrations and plasma renin activity significantly increased during esaxerenone monotherapy at all time points. On the basis of the observations that both urine volume and urinary sodium excretion also decreased up to the end of the study, and were significantly lower at 12 weeks, patients were further categorized into higher/lower urinary sodium excretion subgroups according to whether their baseline values were above or below the median. In the group with higher baseline urinary sodium excretion, esaxerenone exhibited a significantly greater decrease in systolic/diastolic BP compared to the lower baseline group.Esaxerenone exhibited sustained and stable antihypertensive activity even when administered as a single agent for 52 weeks in patients with essential hypertension. The additional urinary biomarker analysis suggests that the BP-lowering effects of esaxerenone may be partly exerted via mechanisms related to salt and water retention, and that the effect is particularly pronounced in patients with hypertension and higher baseline urinary sodium excretion, which may reflect a state of excessive salt intake.NCT02722265." @default.
• W4292113114 created "2022-08-17" @default.
• W4292113114 creator A5006548715 @default.
• W4292113114 creator A5010098499 @default.
• W4292113114 creator A5078329618 @default.
• W4292113114 creator A5091286653 @default.
• W4292113114 date "2022-08-17" @default.
• W4292113114 modified "2023-10-06" @default.
• W4292113114 title "Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect" @default.
• W4292113114 cites W1797367453 @default.
• W4292113114 cites W1983090164 @default.
• W4292113114 cites W1990590422 @default.
• W4292113114 cites W2018678414 @default.
• W4292113114 cites W2031910365 @default.
• W4292113114 cites W2032359266 @default.
• W4292113114 cites W2050263292 @default.
• W4292113114 cites W2121911970 @default.
• W4292113114 cites W2139569559 @default.
• W4292113114 cites W2148105346 @default.
• W4292113114 cites W2173089390 @default.
• W4292113114 cites W2195459026 @default.
• W4292113114 cites W2257451703 @default.
• W4292113114 cites W2325062941 @default.
• W4292113114 cites W2325687991 @default.
• W4292113114 cites W2336167206 @default.
• W4292113114 cites W2466427330 @default.
• W4292113114 cites W2469554148 @default.
• W4292113114 cites W2516664999 @default.
• W4292113114 cites W2906394657 @default.
• W4292113114 cites W2909265208 @default.
• W4292113114 cites W2910448349 @default.
• W4292113114 cites W2916938080 @default.
• W4292113114 cites W2955032344 @default.
• W4292113114 cites W2966611464 @default.
• W4292113114 cites W2977112915 @default.
• W4292113114 cites W2991065707 @default.
• W4292113114 cites W3049471651 @default.
• W4292113114 cites W3101288293 @default.
• W4292113114 cites W3106350466 @default.
• W4292113114 cites W3110801427 @default.
• W4292113114 cites W3119688324 @default.
• W4292113114 cites W4232450481 @default.
• W4292113114 cites W642118772 @default.
• W4292113114 doi "https://doi.org/10.1007/s12325-022-02282-3" @default.
• W4292113114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35976603" @default.
• W4292113114 hasPublicationYear "2022" @default.
• W4292113114 type Work @default.
• W4292113114 citedByCount "4" @default.
• W4292113114 countsByYear W42921131142023 @default.
• W4292113114 crossrefType "journal-article" @default.
• W4292113114 hasAuthorship W4292113114A5006548715 @default.
• W4292113114 hasAuthorship W4292113114A5010098499 @default.
• W4292113114 hasAuthorship W4292113114A5078329618 @default.
• W4292113114 hasAuthorship W4292113114A5091286653 @default.
• W4292113114 hasBestOaLocation W42921131141 @default.
• W4292113114 hasConcept C10146269 @default.
• W4292113114 hasConcept C126322002 @default.
• W4292113114 hasConcept C126894567 @default.
• W4292113114 hasConcept C134018914 @default.
• W4292113114 hasConcept C138976137 @default.
• W4292113114 hasConcept C198710026 @default.
• W4292113114 hasConcept C2777097880 @default.
• W4292113114 hasConcept C2778525890 @default.
• W4292113114 hasConcept C2780018836 @default.
• W4292113114 hasConcept C2780026642 @default.
• W4292113114 hasConcept C2908647359 @default.
• W4292113114 hasConcept C71924100 @default.
• W4292113114 hasConcept C77411442 @default.
• W4292113114 hasConcept C84393581 @default.
• W4292113114 hasConcept C99454951 @default.
• W4292113114 hasConceptScore W4292113114C10146269 @default.
• W4292113114 hasConceptScore W4292113114C126322002 @default.
• W4292113114 hasConceptScore W4292113114C126894567 @default.
• W4292113114 hasConceptScore W4292113114C134018914 @default.
• W4292113114 hasConceptScore W4292113114C138976137 @default.
• W4292113114 hasConceptScore W4292113114C198710026 @default.
• W4292113114 hasConceptScore W4292113114C2777097880 @default.
• W4292113114 hasConceptScore W4292113114C2778525890 @default.
• W4292113114 hasConceptScore W4292113114C2780018836 @default.
• W4292113114 hasConceptScore W4292113114C2780026642 @default.
• W4292113114 hasConceptScore W4292113114C2908647359 @default.
• W4292113114 hasConceptScore W4292113114C71924100 @default.
• W4292113114 hasConceptScore W4292113114C77411442 @default.
• W4292113114 hasConceptScore W4292113114C84393581 @default.
• W4292113114 hasConceptScore W4292113114C99454951 @default.
• W4292113114 hasFunder F4320321625 @default.
• W4292113114 hasIssue "10" @default.
• W4292113114 hasLocation W42921131141 @default.
• W4292113114 hasLocation W42921131142 @default.
• W4292113114 hasLocation W42921131143 @default.
• W4292113114 hasOpenAccess W4292113114 @default.
• W4292113114 hasPrimaryLocation W42921131141 @default.
• W4292113114 hasRelatedWork W1967336868 @default.
• W4292113114 hasRelatedWork W1976450327 @default.
• W4292113114 hasRelatedWork W1995192322 @default.
• W4292113114 hasRelatedWork W2041696910 @default.
• W4292113114 hasRelatedWork W2091766014 @default.
• W4292113114 hasRelatedWork W2099587124 @default.

• next